Neutralization of IL-8 Prevents the Induction of Dermatologic Adverse Events Associated with the Inhibition of Epidermal Growth Factor Receptor-Reference-Cited by-同舟云学术

Neutralization of IL-8 Prevents the Induction of Dermatologic Adverse Events Associated with the Inhibition of Epidermal Growth Factor Receptor

Published:2012-06-25 Issue:6 Volume:7 Page:e39706
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Bangsgaard Nannie,Houtkamp Mischa,Schuurhuis Danita H.,Parren Paul W. H. I.,Baadsgaard Ole,Niessen Hans W. M.,Skov Lone

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference44 articles.

1. The epidermal growth factor receptor is required to maintain the proliferative population in the basal compartment of epidermal tumors.;Cancer Res,2000

2. New advances on the functions of epidermal growth factor receptor and ceramides in skin cell differentiation, disorders and cancers.;M Mimeault;Skin Pharmacol Physiol,2004

3. The erbB family: targets for therapeutic development against cancer and therapeutic strategies using monoclonal antibodies and tyrosine kinase inhibitors.;EK Rowinsky;Annu Rev Med,2004

4. Epidermal growth factor receptor inhibitors in oncology.;I Vivanco;Curr Opin Oncol,2010

5. Dermatologic side effects associated with the epidermal growth factor receptor inhibitors.;AL Agero;J Am Acad Dermatol,2006

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Subcutaneous Administration of Monoclonal Antibodies: Pharmacology, Delivery, Immunogenicity, and Learnings From Applications to Clinical Development;Clinical Pharmacology & Therapeutics;2024-01-10

2. Risk Factor Analysis for Anti-epidermal Growth Factor Receptor Monoclonal Antibody-induced Problematic Skin Toxicities in Patients With Liver Metastatic Colorectal Cancer;In Vivo;2024

3. Risk factor analysis for anti-epidermal growth factor receptor monoclonal antibody–induced skin toxicities in real-world metastatic colorectal cancer treatment;Supportive Care in Cancer;2023-08

4. Dermatological adverse drug reactions to tyrosine kinase inhibitors: a narrative review;Clinical and Experimental Dermatology;2023-02-20

5. Xijiao Dihuang decoction relieves the erlotinib-induced dermatitis;Experimental Cell Research;2023-02